← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-11 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
AntibodystaleMerck Sharp & Dohme LLCPhase 2

Dalotuzumab (Dalotuzumab)

Rectal Neoplasms · Rectal Neoplasms

#RectalNeoplasms#Antibody#Phase2#항체#면역항체+2
효능 ORR 21.6%임상시험 2상태 ACTIVE
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Dan222 + Niraparib (Dan222 + Niraparib)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
CGTBiologicstaleHan weidongPhase 2

Decitabine-primed Tandem CAR19/20 engineered T cells (Decitabine-primed Tandem CAR19/20 engineered T cells)

Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 2상태 RECRUITING
CGTBiologicstaleImmune Design, a subsidiary of …Phase 1

Dendritic Cell-targeting Lentiviral Vector ID-LV305 (Dendritic Cell-targeting Lentiviral Vector ID-LV305)

HLA-A*0201 Positive Cells Present; NY-ESO-1 Positive Tumor Cells Present · HLA-A*0201 Positive Cells Present

#HLA-A0201PositiveCellsPresent#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 2상태 ACTIVE
CGTBiologicstaleCartesian TherapeuticsPhase 2

Descartes-08 (Descartes-08)

Multiple Myeloma · Antisynthetase Syndrome

#AntisynthetaseSyndrome#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 2상태 RECRUITING
ADCBiologicstaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin Combined With PD-1 and Neoadjuvant Chemotherapy)

Gastric Cancer · PD-1

#PD-1#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 ACTIVE
ADCBiologicstaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin combined with Bicalutamide)

Extramammary Paget Disease; Scrotum Disease · Extramammary Paget Disease

#ExtramammaryPagetDisease#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleRemeGenPhase 3

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin+Tislelizumab+Oxaliplatin+Capecitabine)

Gastric Carcinoma · Gastric Carcinoma

#GastricCarcinoma#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 RECRUITING
ADCBiologicstaleThe First Affiliated Hospital w…Preclinical

Disitamb Vedotin (Disitamb Vedotin)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 ACTIVE
CGTBiologicstaleNanjing Legend Biotech Co.Phase 2

Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy (Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy)

Lymphoma, B-Cell · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 2상태 ACTIVE
CGTBiologicstaleBeijing BiotechPhase 2

Dual-target CAR-NK cells (Dual-target CAR-NK cells)

Malignant Glioma; High-Grade Gliomas · Malignant Glioma

#MalignantGlioma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 2상태 RECRUITING
CGTBiologicstaleTScan Therapeutics, Inc.Phase 2

E7 TCR (E7 TCR)

Papillomavirus Infections; Oropharyngeal Neoplasms · Cervical Intraepithelial Neoplasia

#CervicalIntraepithelialNeoplasia#CGT#Phase2#세포유전치료#CAR-T+4
효능 ORR 5%임상시험 2상태 DISCONTINUED
CGTBiologicstaleChristian HinrichsPhase 2

E7 TCR-T cells (E7 TCR-T cells)

HPV-Associated Cervical Carcinoma; HPV-Related Carcinoma · HPV-Associated Cervical Carcinoma

#HPV-AssociatedCervicalCarcinoma#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 5%임상시험 2상태 RECRUITING
ADCBiologicstaleEnliven TherapeuticsPhase 1

ELVN-002 (ELVN-002)

HER2 Mutant Non-small Cell Lung Cancer; HER2-positive Metastatic Breast Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
AntibodystaleRochePhase 1

trastuzumab (Herceptin, EU sourced Herceptin®)

Healthy · Healthy

#Healthy#Antibody#Phase1#항체#면역항체+2
임상시험 2상태 ACTIVE
AntibodystalePfizerPhase 2

Elranatamab-bcmm (Elranatamab-bcmm)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 RECRUITING
AntibodystaleMacroGenicsPhase 3

Enoblituzumab (Enoblituzumab)

Head and Neck Cancer; Squamous Cell Carcinoma of Head and Neck · Head and Neck Cancer

#HeadandNeckCancer#Antibody#Phase3#항체#면역항체+3
효능 ORR 6%임상시험 2상태 DISCONTINUED
ADCBiologicstaleDavid OhPhase 2

Etrumadenant (Etrumadenant)

Prostate Adenocarcinoma; Prostate Cancer · Prostatic Neoplasms, Castration-Resistan

#ProstaticNeoplasmsCastration-Res#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 ACTIVE
ADCBiologicstaleBioAtla, Inc.Phase 2

BA3071 (Evalstotug, Evalstotug (BA3071))

Head and Neck Cancer; Squamous Cell Carcinoma of Head and Neck · Head and Neck Cancer

#HeadandNeckCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 ACTIVE
AntibodystaleNovartisPhase 3

Experimental : Secukinumab low dose (Experimental : Secukinumab low dose)

Chronic Severe Plaque-type Psoriasis · Chronic Severe Plaque-type Psoriasis

#ChronicSeverePlaque-typePsoriasi#Antibody#Phase3#항체#면역항체+2
임상시험 2상태 ACTIVE

68 / 209 페이지

← 이전다음 →